SCHEMBL1664685

SCHEMBL1664685

CCOC(=O)C1=C(C)NC(c2ccccc2)=C(C(=O)OCC)C1c1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 7/20 0.71
TMIGD3 P0DMS9 1/20 0.65
KDM4E B2RXH2 4/20 0.60
ALDH1A1 P00352 4/20 0.60
TSHR P16473 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
TRPV1 Q8NER1 3/20 0.60
CACNA1D Q01668 2/20 0.60
ABCC1 P33527 1/20 0.59
GAA P10253 2/20 0.58
LMNA P02545 2/20 0.58
HPGD P15428 1/20 0.58
HSD17B10 Q99714 1/20 0.58
CACNA1F O60840 1/20 0.55
CACNA1S Q13698 1/20 0.55
CACNA1C Q13936 1/20 0.55
MAPT P10636 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3027412 0.89 ADORA3 (0.89) ADORA3KDM4EALDH1A1TSHRSMN1; SMN2
SCHEMBL1665260 0.88 MAPT (0.68) ADORA3TMIGD3KDM4EALDH1A1TSHR
SCHEMBL11691626 0.86 ADORA3 (0.56) ADORA3TMIGD3KDM4EALDH1A1SMN1; SMN2
SCHEMBL7687629 0.85 ADORA3 (0.75) ADORA3TMIGD3KDM4EALDH1A1TRPV1
SCHEMBL29173863 0.85 ADORA3 (0.82) ADORA3KDM4EALDH1A1TSHRSMN1; SMN2
SCHEMBL10684386 0.83 ADORA3 (0.75) ADORA3KDM4EALDH1A1TSHRSMN1; SMN2
SCHEMBL20610477 0.83 ADORA3 (1.00) ADORA3KDM4EALDH1A1TSHRSMN1; SMN2
SCHEMBL11860075 0.83 ADORA3 (0.80) ADORA3KDM4EALDH1A1TSHRSMN1; SMN2
SCHEMBL11691621 0.83 ADORA3 (0.56) ADORA3TMIGD3KDM4EALDH1A1TSHR
SCHEMBL1664958 0.83 KDM4E (0.80) ADORA3TMIGD3KDM4EALDH1A1TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2311806-A2 Dihydropyridine-, pyridine-, benzopyranone- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists The United States of America, Represented by the Secretary, Department of Health and Human Services (US) 2011-04-20 EP disclosed
US-6066642-A FOR SELECTIVELY BLOCKING THE A3 ADENOSINE RECEPTOR OF A MAMMAL THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2000-05-23 US disclosed